ADMINISTRATIVE CORE ABSTRACT The Administrative Core (AC) is responsible for the overall management and oversight of the Rare Disease Clinical Research Consortia (RDCRC) including developing and implementing policies and procedures, allocating funds, and integrating activities across the 16 sites. The functions of AC include coordinating communication among the sites and integrating participating researchers into a cohesive environment. Additionally, the AC will serve as the point of coordination with the Rare Disease Clinical Research Network (RDCRN) via the Data Management and Coordinating Center (DMCC) and the patient and stakeholder communities through the National Urea Cycle Disorders Foundation. The AC will include a Clinical Team Liaison who will ensure a mutually supportive interaction between the investigators conducting the clinical research projects. The AC will also include an Administrative Coordinator who will be responsible for assisting the Urea Cycle Disorders Consortium (UCDC) PIs with day-to-day administration and program coordination activities. The AC will coordinate and support RDCRN-wide efforts to develop and monitor best practices for clinical and research data handling and use, including the use of common data elements. The AC will maintain a website to inform patients, families, clinicians, researchers, and the general public about ongoing clinical studies in the consortium, resources provided by the DMCC, career enhancement opportunities in the Career Enhancement Core and relevant results from the research studies. The overall responsibilities of the of the AC are described in the following categories: Administration: (a) Overall vision, strategic planning, evaluation and coordination of all UCDC activities; (b) Budget management and resource allocation; (c) Review and supervision of pilot projects; and (d) Organizing Executive Committee, faculty and staff, and External Advisory Committee meetings. Research: (a) Assure efficiency and cost-effectiveness of research projects; and (b) Foster and promote translational research and transdisciplinary collaborations among investigators at the participating institutions. Career Enhancement and Education: (a) Provide mentoring, administrative support and supervision for the career development program; (b) Attract and recruit junior investigators to the UCDC; (c) Facilitate the work of mentors within our training program; and (d) Support and oversee career development activities (grant writing, research projects, presentations, publications). Dissemination: Communicate our research findings by (a) Maintaining a robust website with information about ongoing research, and ways to participate in specific clinical trials and educational activities; b) Providing webcasts and archives on the website of the R25 lectures/seminars; and c) Promoting scientific publications of UCDC investigators.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54HD061221-16
Application #
9804380
Study Section
Special Emphasis Panel (ZTR1)
Project Start
Project End
Budget Start
2019-08-01
Budget End
2020-07-31
Support Year
16
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Children's Research Institute
Department
Type
DUNS #
143983562
City
Washington
State
DC
Country
United States
Zip Code
20010
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Posset, Roland; Garbade, Sven F; Boy, Nikolas et al. (2018) Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-a successful strategy for clinical research of rare diseases. J Inherit Metab Dis :
Nagamani, Sandesh C S; Agarwal, Umang; Tam, Allison et al. (2018) A randomized trial to study the comparative efficacy of phenylbutyrate and benzoate on nitrogen excretion and ureagenesis in healthy volunteers. Genet Med 20:708-716
Sin, Yuan Yan; Ballantyne, Laurel L; Richmond, Christopher R et al. (2018) Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice. Mol Ther Nucleic Acids 10:122-130
Uittenbogaard, Martine; Brantner, Christine A; Chiaramello, Anne (2018) Epigenetic modifiers promote mitochondrial biogenesis and oxidative metabolism leading to enhanced differentiation of neuroprogenitor cells. Cell Death Dis 9:360
Uittenbogaard, Martine; Brantner, Christine A; Fang, ZiShui et al. (2018) Novel insights into the functional metabolic impact of an apparent de novo m.8993T>G variant in the MT-ATP6 gene associated with maternally inherited form of Leigh Syndrome. Mol Genet Metab 124:71-81
Waisbren, Susan E; Cuthbertson, David; Burgard, Peter et al. (2018) Biochemical markers and neuropsychological functioning in distal urea cycle disorders. J Inherit Metab Dis 41:657-667
Sin, Yuan Yan; Price, Phillipe R; Ballantyne, Laurel L et al. (2017) Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency. Sci Rep 7:2585
Burrage, Lindsay C; Miller, Marcus J; Wong, Lee-Jun et al. (2016) Elevations of C14:1 and C14:2 Plasma Acylcarnitines in Fasted Children: A Diagnostic Dilemma. J Pediatr 169:208-13.e2
Merkel, Peter A; Manion, Michele; Gopal-Srivastava, Rashmi et al. (2016) The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis 11:66

Showing the most recent 10 out of 113 publications